Review Article

Phytochemicals against COVID-19: Opportunities and Challenges

Volume: 5 Number: 1 January 24, 2024
EN

Phytochemicals against COVID-19: Opportunities and Challenges

Abstract

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has an urgent need for effective therapeutic agents. In this regard, phytochemicals, bioactive compounds derived from plants, have emerged as potential candidates for the treatment and prevention of COVID-19. This review explores various facets of phytochemical research in relation to COVID-19, ranging from their identification to future perspectives in their application. It sets the stage, describing their nature, classification, and historical use in traditional medicine, alongside their recognized health benefits. We then delve into the methodologies for phytochemical screening, highlighting advanced techniques such as high-performance liquid chromatography (HPLC) and spectroscopic methods, which are pivotal in identifying and characterizing these compounds. In addition, focusing on potential phytochemicals against SARS-CoV-2, we discuss compounds like flavonoids, terpenoids, and alkaloids, which have shown promise in preliminary studies for their antiviral properties. However, the transition from laboratory findings to clinical applications faces challenges, such as issues of bioavailability, lack of clinical trials, and the complexity of phytochemical interactions. Advancements in nanotechnology for drug delivery, exploration of synergistic effects, and personalized medicine are crucial. Therefore, this review underscores the importance of integrating traditional knowledge with modern scientific studies and highlights the need for inclusive clinical studies to validate the efficacy and safety of phytochemicals. The promising yet challenging path of phytochemical research offers a hopeful path in the ongoing battle against COVID-19 and future pandemics.

Keywords

Phytochemicals, COVID-19, Antiviral Properties, Bioavailability, Clinical Trials

References

  1. Arya, P., & Kumar, P. (2023). Phytochemical, phase transition, FTIR, and antimicrobial characterization of defatted Trigonella foenum graecum seed extract as affected by solvent polarity. Journal of Food Measurement and Characterization, 17(5), 5234-5246.
  2. Bellavite, P., & Donzelli, A. (2020). Hesperidin and SARS-CoV-2: New light on the healthy function of citrus fruits. Antioxidants, 9(8), 742.
  3. Chen, H.-F., Wang, W.-J., Chen, C.-Y., Chang, W.-C., Hsueh, P.-R., Peng, S.-L., Wu, C.-S., Chen, Y., Huang, H.-Y., & Shen, W.-J. (2023). The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2. eLife, 12, e84899.
  4. Cheng, H., Mei, J., & Xie, J. (2023). Analysis of key volatile compounds and quality properties of tilapia (Oreochromis mossambicus) fillets during cold storage: Based on thermal desorption coupled with gas chromatography-mass spectrometry (TD-GC-MS). LWT, 184, 115051.
  5. Choi, J. H., Lee, Y. H., Kwon, T. W., Ko, S.-G., Nah, S.-Y., & Cho, I.-H. (2022). Can Panax ginseng help control cytokine storm in COVID-19? Journal of Ginseng Research, 46(3), 337-347.
  6. Dahiya, P., & Purkayastha, S. (2012). Phytochemical screening and antimicrobial activity of some medicinal plants against multi-drug resistant bacteria from clinical isolates. Indian journal of pharmaceutical sciences, 74(5), 443.
  7. Das, K. (2022). Herbal plants as immunity modulators against COVID-19: A primary preventive measure during home quarantine. Journal of Herbal Medicine, 32, 100501. de Souza, A. L. C., do Rego Pires, A., Moraes, C. A. F., de Matos, C. H. C., dos Santos, K. I. P., Campos e Silva, R., Acuña,
  8. S. P. C., & dos Santos Araújo, S. (2023). Chromatographic Methods for Separation and Identification of Bioactive Compounds. In Drug Discovery and Design Using Natural Products (pp. 153-176). Springer.
  9. Derosa, G., Maffioli, P., D'Angelo, A., & Di Pierro, F. (2021). A role for quercetin in coronavirus disease 2019 (COVID‐19). Phytotherapy Research, 35(3), 1230-1236.
  10. Doughari, J. H. (2012). Phytochemicals: extraction methods, basic structures and mode of action as potential chemotherapeutic agents. INTECH Open Access Publisher Rijeka, Croatia. Ghareeb, D. A., Saleh, S. R., Seadawy, M. G., Nofal, M. S., Abdulmalek, S. A., Hassan, S. F., Khedr, S. M., AbdElwahab, M.
APA
Junejo, Y., Safdar, M., & Özaslan, M. (2024). Phytochemicals against COVID-19: Opportunities and Challenges. Zeugma Biological Science, 5(1), 1-8. https://doi.org/10.55549/zbs.1416366
AMA
1.Junejo Y, Safdar M, Özaslan M. Phytochemicals against COVID-19: Opportunities and Challenges. zbs. 2024;5(1):1-8. doi:10.55549/zbs.1416366
Chicago
Junejo, Yasmeen, Muhammad Safdar, and Mehmet Özaslan. 2024. “Phytochemicals Against COVID-19: Opportunities and Challenges”. Zeugma Biological Science 5 (1): 1-8. https://doi.org/10.55549/zbs.1416366.
EndNote
Junejo Y, Safdar M, Özaslan M (January 1, 2024) Phytochemicals against COVID-19: Opportunities and Challenges. Zeugma Biological Science 5 1 1–8.
IEEE
[1]Y. Junejo, M. Safdar, and M. Özaslan, “Phytochemicals against COVID-19: Opportunities and Challenges”, zbs, vol. 5, no. 1, pp. 1–8, Jan. 2024, doi: 10.55549/zbs.1416366.
ISNAD
Junejo, Yasmeen - Safdar, Muhammad - Özaslan, Mehmet. “Phytochemicals Against COVID-19: Opportunities and Challenges”. Zeugma Biological Science 5/1 (January 1, 2024): 1-8. https://doi.org/10.55549/zbs.1416366.
JAMA
1.Junejo Y, Safdar M, Özaslan M. Phytochemicals against COVID-19: Opportunities and Challenges. zbs. 2024;5:1–8.
MLA
Junejo, Yasmeen, et al. “Phytochemicals Against COVID-19: Opportunities and Challenges”. Zeugma Biological Science, vol. 5, no. 1, Jan. 2024, pp. 1-8, doi:10.55549/zbs.1416366.
Vancouver
1.Yasmeen Junejo, Muhammad Safdar, Mehmet Özaslan. Phytochemicals against COVID-19: Opportunities and Challenges. zbs. 2024 Jan. 1;5(1):1-8. doi:10.55549/zbs.1416366